Further mechanistic experiments revealed that epithelial ovarian cancer (EOC) cell treatment with miR-335 results in phenotypes that mimic those induced by abrogated COL11A1 expression and suppresses cell proliferation and invasion, in addition to increasing the sensitivity of EOC cells to cisplatin. Here, COL11A1 is linked to ovarian carcinoma.